Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer

Nicholas Whiting; Jingzhe Hu; Niki M. Zacharias; Ganesh L. R. Lokesh; David E. Volk; David G. Menter; Rajesha Rupaimoole; Rebecca Previs; Anil K. Sood; Pratip Bhattacharya

doi:10.1117/1.JMI.3.3.036001

10 August 2016 Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer

Nicholas Whiting, Jingzhe Hu, Niki M. Zacharias, Ganesh L. R. Lokesh, David E. Volk, David G. Menter, Rajesha Rupaimoole, Rebecca Previs, Anil K. Sood, Pratip Bhattacharya

Author Affiliations +

Journal of Medical Imaging, Vol. 3, Issue 3, 036001 (August 2016). https://doi.org/10.1117/1.JMI.3.3.036001

Abstract

Silicon-based nanoparticles are ideally suited for use as biomedical imaging agents due to their biocompatibility, biodegradability, and simple surface chemistry that facilitates drug loading and targeting. A method of hyperpolarizing silicon particles using dynamic nuclear polarization, which increases magnetic resonance imaging signals by several orders-of-magnitude through enhanced nuclear spin alignment, has recently been developed to allow silicon particles to function as contrast agents for in vivo magnetic resonance imaging. The enhanced spin polarization of silicon lasts significantly longer than other hyperpolarized agents (tens of minutes, whereas <1 min for other species at room temperature), allowing a wide range of potential applications. We report our recent characterizations of hyperpolarized silicon particles, with the ultimate goal of targeted, noninvasive, and nonradioactive molecular imaging of various cancer systems. A variety of particle sizes (20 nm to 2 μm) were found to have hyperpolarized relaxation times ranging from ∼10 to 50 min. The addition of various functional groups to the particle surface had no effect on the hyperpolarization buildup or decay rates and allowed in vivo imaging over long time scales. Additional in vivo studies examined a variety of particle administration routes in mice, including intraperitoneal injection, rectal enema, and oral gavage.

Citation Download Citation

Nicholas Whiting, Jingzhe Hu, Niki M. Zacharias, Ganesh L. R. Lokesh, David E. Volk, David G. Menter, Rajesha Rupaimoole, Rebecca Previs, Anil K. Sood, and Pratip Bhattacharya "Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer," Journal of Medical Imaging 3(3), 036001 (10 August 2016). https://doi.org/10.1117/1.JMI.3.3.036001

Published: 10 August 2016

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available